Zielinski, Robert R., et al. “Population-Based Impact on Overall Survival After the Introduction of Docetaxel As Standard Therapy for Metastatic Castration Resistant Prostate Cancer”. Canadian Urological Association Journal, vol. 8, no. 7-8, Aug. 2014, pp. e520-3, doi:10.5489/cuaj.2076.